CD4+ Lymphocyte Increases in HIV Patients during Potent Antiretroviral Therapy Are Dependent on Inhibition of CD8+ Cell Apoptosis
CD4+ Lymphocyte Increases in HIV Patients during Potent Antiretroviral Therapy Are Dependent on Inhibition of CD8+ Cell Apoptosis
复制标题
DOI:
10.1196/annals.1299.104
复制
发表时间:
2003-12
影响因子:
5.2
通讯作者:
S. Grelli;G. d’Ettore;F. Lauria;F. Montella;L. Traglia;C. D'Agostini;M. Lichtner;V. Vullo;C. Favalli;S. Vella;B. Macchi;A. Mastino
中科院分区:
文献类型:
--
作者:
S. Grelli;G. d’Ettore;F. Lauria;F. Montella;L. Traglia;C. D'Agostini;M. Lichtner;V. Vullo;C. Favalli;S. Vella;B. Macchi;A. Mastino
Abstract: Although suppression of apoptosis contributes to immune‐reconstitution during potent antiretroviral therapy, its relationship with the majors indicators of response to therapy, that is, changes in CD4+ cell counts and in viral loads (VL), is still debated. We extended our previous study by collecting data on the relationships among apoptosis and immunological and virological parameters during a long‐term follow‐up of HIV patients with an overall positive response to potent antiretroviral therapy. We report results from 15 patients who completed two years of therapy. In a smaller group of patients, we focused our attention on investigating the specific contribution of the CD8+ subset in the overall changes in lymphocyte apoptosis, which occur concomitantly with the response to the therapy. Our data, while again confirming that inhibition of PBMC apoptosis is a phenomenon strictly related to a positive response to potent antiretroviral therapy, suggest that CD4+ cell rescue is not directly dependent on inhibition of CD4+ cell apoptosis but rather on that of the CD8+ subset.